Global Submucosal Tissue Lifting Agent 麻豆原创 Research Report 2025

Publication ID:

PB503257296

Publication Date:

March 5, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Submucosal Tissue Lifting Agent was valued at US$ 169 million in the year 2024 and is projected to reach a revised size of US$ 254 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Submucosal Tissue Lifting Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
With the continuous advancement of medical technology, submucosal tissue lifting using injection agents has emerged as an innovative medical approach, garnering increasing attention and adoption. This technique involves injecting specific solutions into the submucosal layer, causing localized tissue elevation to facilitate diagnostic, therapeutic, and surgical procedures under endoscopic guidance. This method holds potential advantages in early screening and treatment of gastrointestinal pathologies, not only enhancing lesion visibility but also reducing surgical risks and recovery times. The market for this technology is exhibiting a steady growth trajectory, driven by its application prospects in the field of minimally invasive interventions. As awareness of health rises and the demand for early disease diagnosis and treatment increases, the development and application of submucosal tissue lifting solutions have gained momentum. Simultaneously, ongoing innovations in medical devices and pharmaceuticals provide robust support for the refinement and wider adoption of this technique. However, challenges such as standardization of technical protocols and accumulation of clinical evidence still exist in the market, necessitating close collaboration between relevant manufacturers and healthcare institutions to collectively propel the advancement of this field.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Submucosal Tissue Lifting Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Tissue Lifting Agent.
The Submucosal Tissue Lifting Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Submucosal Tissue Lifting Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Tissue Lifting Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seikagaku
Ovesco Endoscopy
Boston Scientific
The Standard
GI Supply
Cosmo Pharmaceuticals
Micro-Tech Endoscopy
EndoClot Plus
Segment by Type
Prefilled Syringe Type
Ampoule Type
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Submucosal Tissue Lifting Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Submucosal Tissue Lifting Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Submucosal Tissue Lifting Agent 麻豆原创 Overview
1.1 Product Definition
1.2 Submucosal Tissue Lifting Agent by Type
1.2.1 Global Submucosal Tissue Lifting Agent 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Prefilled Syringe Type
1.2.3 Ampoule Type
1.3 Submucosal Tissue Lifting Agent by Application
1.3.1 Global Submucosal Tissue Lifting Agent 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Global Submucosal Tissue Lifting Agent 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Submucosal Tissue Lifting Agent Revenue 2020-2031
1.4.2 Global Submucosal Tissue Lifting Agent Sales 2020-2031
1.4.3 Global Submucosal Tissue Lifting Agent 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Submucosal Tissue Lifting Agent 麻豆原创 Competition by Manufacturers
2.1 Global Submucosal Tissue Lifting Agent Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Submucosal Tissue Lifting Agent Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Submucosal Tissue Lifting Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Submucosal Tissue Lifting Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Submucosal Tissue Lifting Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Submucosal Tissue Lifting Agent, Product Type & Application
2.7 Global Key Manufacturers of Submucosal Tissue Lifting Agent, Date of Enter into This Industry
2.8 Global Submucosal Tissue Lifting Agent 麻豆原创 Competitive Situation and Trends
2.8.1 Global Submucosal Tissue Lifting Agent 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Submucosal Tissue Lifting Agent Players 麻豆原创 Share by Revenue
2.8.3 Global Submucosal Tissue Lifting Agent 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Submucosal Tissue Lifting Agent 麻豆原创 Scenario by Region
3.1 Global Submucosal Tissue Lifting Agent 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Submucosal Tissue Lifting Agent Sales by Region: 2020-2031
3.2.1 Global Submucosal Tissue Lifting Agent Sales by Region: 2020-2025
3.2.2 Global Submucosal Tissue Lifting Agent Sales by Region: 2026-2031
3.3 Global Submucosal Tissue Lifting Agent Revenue by Region: 2020-2031
3.3.1 Global Submucosal Tissue Lifting Agent Revenue by Region: 2020-2025
3.3.2 Global Submucosal Tissue Lifting Agent Revenue by Region: 2026-2031
3.4 North America Submucosal Tissue Lifting Agent 麻豆原创 Facts & Figures by Country
3.4.1 North America Submucosal Tissue Lifting Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Submucosal Tissue Lifting Agent Sales by Country (2020-2031)
3.4.3 North America Submucosal Tissue Lifting Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Submucosal Tissue Lifting Agent 麻豆原创 Facts & Figures by Country
3.5.1 Europe Submucosal Tissue Lifting Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Submucosal Tissue Lifting Agent Sales by Country (2020-2031)
3.5.3 Europe Submucosal Tissue Lifting Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Submucosal Tissue Lifting Agent 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Submucosal Tissue Lifting Agent 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Submucosal Tissue Lifting Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Submucosal Tissue Lifting Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Submucosal Tissue Lifting Agent 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Submucosal Tissue Lifting Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Submucosal Tissue Lifting Agent Sales by Country (2020-2031)
3.7.3 Latin America Submucosal Tissue Lifting Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Submucosal Tissue Lifting Agent 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Submucosal Tissue Lifting Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Submucosal Tissue Lifting Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Submucosal Tissue Lifting Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Submucosal Tissue Lifting Agent Sales by Type (2020-2031)
4.1.1 Global Submucosal Tissue Lifting Agent Sales by Type (2020-2025)
4.1.2 Global Submucosal Tissue Lifting Agent Sales by Type (2026-2031)
4.1.3 Global Submucosal Tissue Lifting Agent Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Submucosal Tissue Lifting Agent Revenue by Type (2020-2031)
4.2.1 Global Submucosal Tissue Lifting Agent Revenue by Type (2020-2025)
4.2.2 Global Submucosal Tissue Lifting Agent Revenue by Type (2026-2031)
4.2.3 Global Submucosal Tissue Lifting Agent Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Submucosal Tissue Lifting Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Submucosal Tissue Lifting Agent Sales by Application (2020-2031)
5.1.1 Global Submucosal Tissue Lifting Agent Sales by Application (2020-2025)
5.1.2 Global Submucosal Tissue Lifting Agent Sales by Application (2026-2031)
5.1.3 Global Submucosal Tissue Lifting Agent Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Submucosal Tissue Lifting Agent Revenue by Application (2020-2031)
5.2.1 Global Submucosal Tissue Lifting Agent Revenue by Application (2020-2025)
5.2.2 Global Submucosal Tissue Lifting Agent Revenue by Application (2026-2031)
5.2.3 Global Submucosal Tissue Lifting Agent Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Submucosal Tissue Lifting Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seikagaku
6.1.1 Seikagaku Company Information
6.1.2 Seikagaku Description and Business Overview
6.1.3 Seikagaku Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seikagaku Submucosal Tissue Lifting Agent Product Portfolio
6.1.5 Seikagaku Recent Developments/Updates
6.2 Ovesco Endoscopy
6.2.1 Ovesco Endoscopy Company Information
6.2.2 Ovesco Endoscopy Description and Business Overview
6.2.3 Ovesco Endoscopy Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ovesco Endoscopy Submucosal Tissue Lifting Agent Product Portfolio
6.2.5 Ovesco Endoscopy Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Submucosal Tissue Lifting Agent Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 The Standard
6.4.1 The Standard Company Information
6.4.2 The Standard Description and Business Overview
6.4.3 The Standard Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 The Standard Submucosal Tissue Lifting Agent Product Portfolio
6.4.5 The Standard Recent Developments/Updates
6.5 GI Supply
6.5.1 GI Supply Company Information
6.5.2 GI Supply Description and Business Overview
6.5.3 GI Supply Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GI Supply Submucosal Tissue Lifting Agent Product Portfolio
6.5.5 GI Supply Recent Developments/Updates
6.6 Cosmo Pharmaceuticals
6.6.1 Cosmo Pharmaceuticals Company Information
6.6.2 Cosmo Pharmaceuticals Description and Business Overview
6.6.3 Cosmo Pharmaceuticals Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cosmo Pharmaceuticals Submucosal Tissue Lifting Agent Product Portfolio
6.6.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.7 Micro-Tech Endoscopy
6.7.1 Micro-Tech Endoscopy Company Information
6.7.2 Micro-Tech Endoscopy Description and Business Overview
6.7.3 Micro-Tech Endoscopy Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Micro-Tech Endoscopy Submucosal Tissue Lifting Agent Product Portfolio
6.7.5 Micro-Tech Endoscopy Recent Developments/Updates
6.8 EndoClot Plus
6.8.1 EndoClot Plus Company Information
6.8.2 EndoClot Plus Description and Business Overview
6.8.3 EndoClot Plus Submucosal Tissue Lifting Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 EndoClot Plus Submucosal Tissue Lifting Agent Product Portfolio
6.8.5 EndoClot Plus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Submucosal Tissue Lifting Agent Industry Chain Analysis
7.2 Submucosal Tissue Lifting Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Submucosal Tissue Lifting Agent Production Mode & Process Analysis
7.4 Submucosal Tissue Lifting Agent Sales and 麻豆原创ing
7.4.1 Submucosal Tissue Lifting Agent Sales Channels
7.4.2 Submucosal Tissue Lifting Agent Distributors
7.5 Submucosal Tissue Lifting Agent Customer Analysis
8 Submucosal Tissue Lifting Agent 麻豆原创 Dynamics
8.1 Submucosal Tissue Lifting Agent Industry Trends
8.2 Submucosal Tissue Lifting Agent 麻豆原创 Drivers
8.3 Submucosal Tissue Lifting Agent 麻豆原创 Challenges
8.4 Submucosal Tissue Lifting Agent 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Seikagaku
Ovesco Endoscopy
Boston Scientific
The Standard
GI Supply
Cosmo Pharmaceuticals
Micro-Tech Endoscopy
EndoClot Plus

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.